UKALL 2003
Trial overview
Please copy and paste the URL below into a new window for more information on UKALL 2003:
Then go to 'Projects', 'UKALL2003'
Contact details
Other trials currently active for Acute Lymphoblastic Leukaemia
Minimal Residual Disease monitoring in adult acute lymphoblastic leukaemia: a laboratory feasibility study.
A randomized trial for adults with newly diagnosed acute lymphoblastic leukaemia.
For precursor-B lineage ALL, the main aim is to determine if the addition of Rituximab to standard induction chemotherapy results in improved EFS.
For T lineage ALL, the main aim is to determine if the addition of nelarabine following standard induction therapy improves outcomes.